Author

T. Bonafé

h-index 0 View on Semantic Scholar

We have 3 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Perioperative empagliflozin and risk of acute kidney injury after cardiac surgery: a systematic review and meta-analysis

Hypertension is the leading modifiable risk factor for cardiovascular disease globally, driven by a sodium-rich, potassium-poor dietary phenotype. Whilst potassium-enriched salt substitutes (PESS) demonstrate hypotensive potential, widespread clinical implementation is hindered by theoretical concerns regarding f...

G. Â. Alves, T. Bonafé, B. Souza et al. · European Heart Journal · 0 citations

Review Open access Oct 2026

Effects of fecal microbiota transplantation in patients with Parkinson’s disease and amyotrophic lateral sclerosis: systematic review and meta-analysis

Although the intervention does not significantly reduce motor symptoms, it may be associated with consistent benefits in anxiety and constipation-related quality of life, suggesting an overall improvement in quality of life.

Matheus de Souza Ribeiro, T. Bonafé, Heloísa Rodrigues Bariviera et al. · ANPAbstract_CBN26 · 0 citations

Review Open access Oct 2026

Efficacy and safety of zilebesiran for inadequately controlled hypertension: a systematic review and meta-analysis

Hypertension remains the leading modifiable risk factor for cardiovascular disease, yet control rates are suboptimal due to poor adherence and blood pressure (BP) variability with daily oral regimens. Zilebesiran is an investigational RNA interference therapeutic targeting hepatic angiotensinogen (AGT) synthesis....

T. Bonafé, G. A. Alves, B. M. Gomes et al. · European Heart Journal · 0 citations